Why is P & G Health Ltd falling/rising?

As of 04-Aug, Procter & Gamble Health Ltd is experiencing a price increase, currently at 6,298.00, reflecting a rise of 81.0 points or 1.3%. The stock has shown strong performance recently, gaining 7.53% over the past week and 9.53% over the last month, while it is also close to its 52-week high, just 3.21% away. Today's trading saw the stock open with a gain of 4.23% and reach an intraday high of Rs 6479.95. The stock has been gaining for the last two days, with a total return of 7.19% during this period. Positive factors contributing to this rise include high management efficiency, a low debt-to-equity ratio, and consistently positive quarterly results. Additionally, the stock has a high institutional holding of 21.15%, indicating strong investor confidence.
In the broader market context, P & G Health Ltd has significantly outperformed the benchmark, with a return of 18.61% over the past year compared to the Sensex's minimal gain of 0.05%. This performance is particularly notable given the negative returns of -2.34% from the broader BSE500 index over the same period. The stock's ability to generate positive returns despite a challenging market environment underscores its strong fundamentals and investor interest, which are further supported by rising delivery volumes and favorable moving averages. However, it is important to note that while the stock is performing well in the short term, there are concerns regarding its long-term growth potential, as indicated by modest sales growth rates.